TR200101336T2 - Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar - Google Patents

Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar

Info

Publication number
TR200101336T2
TR200101336T2 TR2001/01336T TR200101336T TR200101336T2 TR 200101336 T2 TR200101336 T2 TR 200101336T2 TR 2001/01336 T TR2001/01336 T TR 2001/01336T TR 200101336 T TR200101336 T TR 200101336T TR 200101336 T2 TR200101336 T2 TR 200101336T2
Authority
TR
Turkey
Prior art keywords
agonist
beta
combinations
antidiabetic agent
another antidiabetic
Prior art date
Application number
TR2001/01336T
Other languages
English (en)
Inventor
Robert Sanders Arch Jonathan
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9824789.3A external-priority patent/GB9824789D0/en
Priority claimed from GBGB9824791.9A external-priority patent/GB9824791D0/en
Priority claimed from GBGB9824790.1A external-priority patent/GB9824790D0/en
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of TR200101336T2 publication Critical patent/TR200101336T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)

Abstract

Bir memelide, örnegin bir insanda diyabet mellitusun ve diyabet mellitus ile ilgili vakalarin tedavisi için, ihtiyaç duyan memeliye bir beta antagonisti ve baska bir antidiyabetik maddeden, etkili, toksik olmayan ve farmasötik olarak kabul edilebilir bir miktarda verilmesini içeren bir yöntem.
TR2001/01336T 1998-11-11 1999-11-11 Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar TR200101336T2 (tr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9824789.3A GB9824789D0 (en) 1998-11-11 1998-11-11 Novel method of treatment
GBGB9824791.9A GB9824791D0 (en) 1998-11-11 1998-11-11 Novel methods of treatment
GBGB9824790.1A GB9824790D0 (en) 1998-11-11 1998-11-11 Novel method of treatment

Publications (1)

Publication Number Publication Date
TR200101336T2 true TR200101336T2 (tr) 2001-11-21

Family

ID=27269550

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/01336T TR200101336T2 (tr) 1998-11-11 1999-11-11 Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar

Country Status (15)

Country Link
EP (1) EP1128845A1 (tr)
JP (1) JP2002529430A (tr)
KR (1) KR20010075698A (tr)
CN (1) CN1332638A (tr)
AU (1) AU766928B2 (tr)
BR (1) BR9915214A (tr)
CA (1) CA2350062A1 (tr)
CZ (1) CZ20011655A3 (tr)
HK (1) HK1041201A1 (tr)
HU (1) HUP0104388A3 (tr)
IL (1) IL143004A0 (tr)
NO (1) NO20012300L (tr)
PL (1) PL348154A1 (tr)
TR (1) TR200101336T2 (tr)
WO (1) WO2000027434A1 (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007201729B2 (en) * 1999-12-23 2010-02-25 Novartis Ag Use of hypoglycemic agent for treating impaired glucose metabolism
CA2393083C (en) * 1999-12-23 2010-01-26 Novartis Ag Use of hypoglycemic agent for treating impaired glucose metabolism
EP1261373A2 (en) * 1999-12-24 2002-12-04 SmithKline Beecham plc Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions
US20030018061A1 (en) * 2000-01-28 2003-01-23 Kohei Ogawa Novel remedies with the use of beta 3 agonist
AU2001252575A1 (en) * 2000-04-28 2001-11-12 Asahi Kasei Kabushiki Kaisha Novel tricyclic compounds
AU2001252573A1 (en) * 2000-04-28 2001-11-12 Asahi Kasei Kabushiki Kaisha Novel substituted tricyclic compounds
WO2006132196A1 (ja) * 2005-06-08 2006-12-14 Asahi Kasei Pharma Corporation β３作動薬を含有する新規な医薬
US11053255B2 (en) 2015-06-22 2021-07-06 Georgetown University Synthesis of mahanine and related compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69100282T3 (de) * 1990-02-09 2001-01-11 Pharmacia & Upjohn Co., Kalamazoo Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie.
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
CA2242351C (en) * 1996-01-10 2003-03-11 Asahi Kasei Kogyo Kabushiki Kaisha Novel tricyclic compounds and drug compositions containing the same

Also Published As

Publication number Publication date
EP1128845A1 (en) 2001-09-05
WO2000027434A1 (en) 2000-05-18
NO20012300D0 (no) 2001-05-10
HK1041201A1 (zh) 2002-07-05
CN1332638A (zh) 2002-01-23
PL348154A1 (en) 2002-05-06
HUP0104388A2 (hu) 2002-03-28
KR20010075698A (ko) 2001-08-09
AU766928B2 (en) 2003-10-23
IL143004A0 (en) 2002-04-21
CZ20011655A3 (cs) 2002-06-12
CA2350062A1 (en) 2000-05-18
NO20012300L (no) 2001-07-03
HUP0104388A3 (en) 2002-12-28
AU1063400A (en) 2000-05-29
BR9915214A (pt) 2001-12-18
JP2002529430A (ja) 2002-09-10

Similar Documents

Publication Publication Date Title
TR199903057T2 (tr) Diabetin tiazolidinedion ve metformin ile tedavisi.
MXPA02012763A (es) Combinaciones de inhibidores de dipeptidil peptidasa iv y otros agentes antidiabeticos para el tratamiento de diabetes mellitus.
TR200102977T2 (tr) Yeni tedavi yöntemi.
YU37301A (sh) Farmaceutski preparat za modifikovano oslobađanje sensitizera insulina i drugog antidijabetskog agensa
IT1302307B1 (it) Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil
CA2023630A1 (en) Use of toremifene and its metabolites for the reversal of multidrug resistance of cancer cells against cytotoxic drugs
BG95935A (bg) Метод и средство за приемане на дексмедетомидин директно през кожата
TR200101336T2 (tr) Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar
EA200000139A1 (ru) Лечение диабета тиазолидиндионом, средством, стимулирующим секрецию инсулина, и дигуанидом
ES2131122T3 (es) Uso de il-10 para prevenir la diabetes mellitus dependiente de insulina.
TR200503846T2 (tr) Değiştirilmiş salimli ensülin sensitizörü için fterkip ve kullanımı
EA200000042A1 (ru) Способ лечения диабета росиглитазоном и инсулином
EP1621207A3 (en) Mixture of defibrotide and G-CSF, and its use for activating haematopoietic progenitors
AP2000001735A0 (en) Treatment of diabetes with thiazolidinedione insulin secretagogue and alpha glucocidase inhibitor.
TR199903072T2 (tr) Diabetin tiazolidinedion ve alfa-glukosidaz ile tedavisi.
TR200000135T2 (tr) Tiazolidinedion ve sülfonilüre ile diabet tedavisi.
AR008025A1 (es) Combinación farmacéutica de una tiazolidindiona y un secretagogo de insulina
FI850644A7 (fi) Menettelytapa in vitro -taudinmäärityksessä ja taudinmääritysaine.
NZ506406A (en) Compositions comprising Mycobacterium phlei DNA and methods for its use in the treatment of bladder cancer
TR200000957T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı
WO2001047509A3 (en) Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions
TR200000958T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı.
CO5150158A1 (es) Tratamiento antidiabetico novedoso
ES1011560U (es) Compresa higienica femenina.
ECSP982592A (es) Nuevo metodo de tratamiento v